State of the Art: Imaging for Myocardial Viability: A Scientific Statement From the American Heart Association
Authors:
- Mario J. GarciaMGMario J. Garcia
- Raymond Y. KwongRKRaymond Y. Kwong
- Marielle Scherrer-CrosbieMSMarielle Scherrer-Crosbie
- Cynthia C. TaubCTCynthia C. Taub
- Ron BlanksteinRBRon Blankstein
- João LimaJLJoão Lima
- Robert O. BonowRBRobert O. Bonow
- Parham EshtehardiPEParham Eshtehardi
- John P. BoisJBJohn P. Bois
- On behalf of the American Heart Association Council on Cardiovascular Radiology and Intervention and Council on Clinical CardiologyOCOn behalf of the American Heart Association Council on Cardiovascular Radiology and Intervention and Council on Clinical Cardiology
- 1 July 2020
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 13 (7) , e000053
Abstract
A substantial proportion of patients with acute myocardial infarction develop clinical heart failure, which remains a common and major healthcare burden. It has been shown that in patients with chronic coronary artery disease, ischemic episodes lead to a global pattern of cardiomyocyte remodeling and dedifferentiation, hallmarked by myolysis, glycogen accumulation, and alteration of structural proteins. These changes, in conjunction with an impaired global coronary reserve, may eventually become irreversible and result in ischemic cardiomyopathy. Moreover, noninvasive imaging of myocardial scar and hibernation can inform the risk of sudden cardiac death. Therefore, it would be intuitive that imaging of myocardial viability is an essential tool for the proper use of invasive treatment strategies and patient prognostication. However, this notion has been challenged by large-scale clinical trials demonstrating that, in the modern era of improved guideline-directed medical therapies, imaging of myocardial viability failed to deliver effective guidance of coronary bypass surgery to a reduction of adverse cardiac outcomes. In addition, current available imaging technologies in this regard are numerous, and they target diverse surrogates of structural or tissue substrates of myocardial viability. In this document, we examine these issues in the current clinical context, collect current evidence of imaging technology by modality, and inform future directions.Keywords
This publication has 65 references indexed in Scilit:
- Impact of Coronary Microvascular Function on Long-term Cardiac Mortality in Patients With Acute ST-Segment–Elevation Myocardial InfarctionCirculation: Cardiovascular Interventions, 2013
- Comparison of99mTc-N-DBODC5 and99mTc-MIBI of Myocardial Perfusion Imaging for Diagnosis of Coronary Artery DiseaseBioMed Research International, 2013
- Myocardial Viability and Survival in Ischemic Left Ventricular DysfunctionNew England Journal of Medicine, 2011
- Usefulness of the index of microcirculatory resistance for invasively assessing myocardial viability immediately after primary angioplasty for anterior myocardial infarctionEuropean Heart Journal, 2009
- Contrast-Enhanced Multidetector Computed Tomography Viability Imaging After Myocardial InfarctionCirculation, 2006
- Hibernating MyocardiumCirculation Research, 2004
- Rest technetium-99m sestmibi temography in combination with short-term administration of nitrates: Feasibility and reliability for prediction of postrevascularization outcome of asynergic territoriesJACC, 1994
- Computed tomography for localization and sizing of experimental acute myocardial infarcts.Circulation, 1978
- Uptake of Contrast Materials by Experimental Acute Myocardial Infarctions: A Preliminary ReportInvestigative Radiology, 1978
- Intervention ventriculography. Comparative value of nitroglycerin, post-extrasystolic potentiation and nitroglycerin plus post-extrasystolic potentiation.Circulation, 1976